Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.

OBJECTIVE--To evaluate the efficacy of high-dose verapamil treatment (240 mg twice daily) in the prevention of angiographic restenosis after primary successful coronary angioplasty in patients at high risk of recurrent obstruction. DESIGN--A placebo controlled, double blind trial in which patients w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Br Heart J
Autores principales: Hoberg, E., Dietz, R., Frees, U., Katus, H. A., Rauch, B., Schömig, A., Schuler, G., Schwarz, F., Tillmanns, H., Niebauer, J.
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC483663/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8142195/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.71.3.254
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares